SEC
SlamSEC
SearchBrowseEarnings

Voyager Therapeutics, Inc.

Nasdaq:VYGR
Biological Products, (No Diagnostic Substances)·LEXINGTON, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(645 total)

TypeDateAccessionPeriodSize
8-K
Mar 9, 2026
0001104659-26-0252018-K
Mar 9, 2026
336.6 KB
10-K
Mar 9, 2026
0001104659-26-02519710-K
Dec 31, 2025
13.7 MB
4
Feb 26, 2026
0001104659-26-020183OWNERSHIP DOCUMENT
Feb 24, 2026
5.6 KB
4
Feb 26, 2026
0001104659-26-020181OWNERSHIP DOCUMENT
Feb 24, 2026
5.6 KB
4
Feb 26, 2026
0001104659-26-020179OWNERSHIP DOCUMENT
Feb 24, 2026
19.9 KB
4
Feb 26, 2026
0001104659-26-020176OWNERSHIP DOCUMENT
Feb 24, 2026
5.6 KB
144
Feb 24, 2026
0001959173-26-001451
—
5.4 KB
144
Feb 24, 2026
0001959173-26-001449
—
4.3 KB
144
Feb 24, 2026
0001959173-26-001448
—
5.4 KB
144
Feb 24, 2026
0001959173-26-001447
—
5.5 KB
4
Feb 20, 2026
0001104659-26-018131OWNERSHIP DOCUMENT
Feb 18, 2026
20.5 KB
4
Feb 20, 2026
0001104659-26-018130OWNERSHIP DOCUMENT
Feb 18, 2026
19.7 KB
4
Feb 20, 2026
0001104659-26-018126OWNERSHIP DOCUMENT
Feb 18, 2026
22.0 KB
144
Feb 18, 2026
0001959173-26-001156
—
4.9 KB
144
Feb 18, 2026
0001959173-26-001151
—
4.9 KB
144
Feb 18, 2026
0001959173-26-001148
—
4.9 KB
SCHEDULE 13G/A
Feb 18, 2026
0001172661-26-001298
—
10.1 KB
SCHEDULE 13G/A
Feb 17, 2026
0000935836-26-000117
—
16.0 KB
8-K
Feb 12, 2026
0001104659-26-013897FORM 8-K
Feb 9, 2026
186.0 KB
4
Feb 11, 2026
0001104659-26-013416OWNERSHIP DOCUMENT
Feb 10, 2026
5.5 KB
4
Feb 11, 2026
0001104659-26-013414OWNERSHIP DOCUMENT
Feb 10, 2026
5.4 KB
4
Feb 11, 2026
0001104659-26-013408OWNERSHIP DOCUMENT
Feb 10, 2026
5.5 KB
4
Feb 10, 2026
0001104659-26-012679OWNERSHIP DOCUMENT
Feb 6, 2026
8.0 KB
4
Feb 10, 2026
0001104659-26-012677OWNERSHIP DOCUMENT
Feb 6, 2026
8.0 KB
4
Feb 10, 2026
0001104659-26-012675OWNERSHIP DOCUMENT
Feb 6, 2026
8.0 KB
25 filings shown
CEO
Sandrock Alfred
CFO
Jorgensen Nathan D.